@ClimedoHealth

The leading European #eCOA system for non-interventional studies, RWE & launch success. Industries: #Pharma #MedTech #CROs Solutions: #EDC #ePRO #eConsent

 Munich, Germany
climedo.de/en
Joined December 2019
  • Tweets1.4K
  • Following1.2K
  • Followers380
471Media
43 neue Medikamente in Deutschland zugelassen, davon 27 für seltene Erkrankungen – ein Fortschritt für Patient:innen! Auch RSV-Impfstoffe & Reserveantibiotika dabei. Trotzdem bleibt Handlungsbedarf bei Antibiotika-Resistenzen. Mehr im @Dt_Aerzteblatt: eu1.hubs.ly/H0fTc1C0
33
Missed our Climedo Connect on DTx back in September? Now’s your chance to catch up! 🎥 Watch the webinar on demand now eu1.hubs.ly/H0fwwJn0 #DigitalTherapeutics #DTx #HealthcareInnovation #ClimedoConnect

Climedo Connect | Digital Therapeutics Unmasked: What Does the Future Hold?

Climedo Connect: Digital Therapeutics Unmasked: What Does the Future Hold?

discover.climedo.com
63
Revolutionizing Clinical Trials with Digital Twins. With the market for digital twins in clinical trials projected to grow from $1.17 billion in 2022 to $38.43 billion by 2032, this technology is set to accelerate breakthroughs in personalized medicine. eu1.hubs.ly/H0fwwkk0
20
Missed our #ClimedoConnect webinar back in Oct? Watch the on-demand session to explore how combining Patient Centricity with Real-World Evidence (RWE) is transforming healthcare: eu1.hubs.ly/H0ftRFk0

Climedo Connect | RWE and Patient Centricity – How Each Amplifies and Promotes the Other

Climedo Connect: RWE and Patient Centricity – How Each Amplifies and Promotes the Other

discover.climedo.com
16
🌟 Early cineole use can significantly reduce common cold symptoms & recovery time. 📉 Patients treated within 12h saw a 38% lower symptom burden. Data captured seamlessly via Climedo's eDiary ensured real-time, accurate insights. eu1.hubs.ly/H0ftR330

The impact of cineole treatment timing on common cold duration and symptoms: Non-randomized...

Introduction Common cold (CC) symptoms arise from an inflammatory response treatable with cineole and generally peak within two days, which complicates research implementation. We therefore explored...

journals.plos.org
15
Unstructured data in #RWE studies is no longer a challenge—thanks to #GenAI! 🌟 Discover how GenAI is transforming clinical notes, patient feedback & more into actionable insights. Faster, smarter, better healthcare outcomes await. 🧠 Learn more: eu1.hubs.ly/H0ftRDV0

From Chaos to Clarity: Using GenAI to Structure Unstructured Data

Find out more about the potential of GenAI when it comes to structuring of unstructured data in RWE studies.

climedo.de
17
Breaking Barriers to Access in Oncology 📊 Faster decisions in some EU markets ⏳ Delays persist for combo therapies in others 🔬 RWE & mature data key to success IQVIA's ISPOR EU 2024 study reveals trends in patient access to innovation across UK & EU. eu1.hubs.ly/H0ftPpj0
30
This International Women’s Day 2025, we’re stepping forward in solidarity to help #AccelerateAction for gender equality. Join us on March 8 and take decisive steps to accelerate the momentum for change. 🌍💜
10
Why KOL Engagement Matters in Phase IV Trials 💡 Build trust through open dialogue 📊 Share real-time data via dashboards 🔬 Involve KOLs in cutting-edge discoveries Engage effectively to boost credibility, data collection and patient access to treatments eu1.hubs.ly/H0ftR1G0

Engaging KOLs in the Post-Approval Phase – 3 Expert Tips

This article will discuss why engaging KOLs in the Post-Approval Phase is so important for trial sponsors and how to go about it.

climedo.de
7
This #RareDiseaseDay, Climedo supports innovative treatments for rare diseases with cutting-edge clinical trial solutions. Let’s unite for the 300M people living with rare diseases and advocate for equity in healthcare and diagnosis. 💙💚💜 #ClinicalTrials #EquityForRareDiseases
14
Just 1 week to go before we discuss omnichannel innovation for rare disease Medical Affairs in our #ClimedoConnect with @novonordisk – join us on February 26 to talk about crafting omnichannel strategies for rare disease medical affairs: eu1.hubs.ly/H0fvY8Y0
9
Getting Drugs to Patients Faster. Colleen Dixon: Pharma 4.0 + AI = streamlined processes & faster tech transfer 🚀 Mary Lou Glotzbach: Patient-centric delivery + sustainability 🌍 Learn more via @medicine_maker eu1.hubs.ly/H0ftC8y0
1
11
In case you missed one of our top blog posts last year on our trial physician survey results – here's a quick recap. 🔍 eu1.hubs.ly/H0fRdD70

Trial Physician Survey: Status Quo in Clinical Research | Climedo

Learn more about the view of physicians on the current status quo of clinical research from our latest trial physician survey.

climedo.de
5
Eine Umfrage zeigt: 2/3 der Ärzte sehen KI als Schlüssel für bessere Versorgung und Entlastung. Doch es besteht großer Weiterbildungsbedarf – gerade bei Haftungsfragen und Kontrollverlust. Mehr dazu im @Dt_Aerzteblatt: eu1.hubs.ly/H0ftBqs0

Ärzte sehen großen Weiterbildungsbedarf bei Künstlicher Intelligenz – Deutsches Ärzteblatt

aerzteblatt.de
8
Ready to take your HCP engagement to the next level? Join us on February 26, 2025, at 3 PM CET for an exclusive webinar: "Connecting the Dots: Omnichannel Engagement in Rare Disease Medical Affairs." eu1.hubs.ly/H0fvYqr0
8
It's #WorldCancerDay. 💙 Join us this February 4 as we stand together for a future where cancer care is about more than just treatment—it’s about people.
2
Generative AI could cut costs, save time, & increase equity in clinical trials. 5 possibilities: 1️⃣ Faster trial design 2️⃣ Smarter site selection 3️⃣ Diverse patient recruitment 4️⃣ Automated data analysis 5️⃣ Streamlined regulatory submission eu1.hubs.ly/H0fn_bh0

GenAI in clinical trials: Challenges, solutions and results | World Economic Forum

New research explains how genAI could transform clinical trials around the world, as well as how to overcome the main barriers to make this a reality.

weforum.org
6
In her guest blog post, Patient Expert Clarinda Cerejo describes the meaning of empathy in a clinical context, why it is missing in clinical interactions and whether empathy can be taught. She also looks at the role of AI. Read her full blog post here: eu1.hubs.ly/H0ftBZM0

A New Era of Empathy in Patient Interactions

Find out more about empathy emerging as one of the most critical yet often overlooked elements in patient care.

climedo.de
6
💡 Building Responsible AI in Healthcare 💡 A new case study from the Mass General Brigham AI Governance Committee offers a blueprint for integrating artificial intelligence (AI) into healthcare responsibly. eu1.hubs.ly/H0f79Ct0

Establishing responsible use of AI guidelines: a comprehensive case study for healthcare institut...

npj Digital Medicine - Establishing responsible use of AI guidelines: a comprehensive case study for healthcare institutions

nature.com
8
How can medical affairs teams meet HCPs’ rising expectations for connected communication while optimizing ROI? The answer lies in omnichannel engagement. Don’t miss our upcoming webinar on February 26: eu1.hubs.ly/H0fvXC00
8
Load more